Isracann Biosciences, Inc. engages in the distribution and cultivation of medical cannabis for the Israeli medical cannabis market. The company was founded on January 21, 2010, and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company